COLL vs DHR · P/E 17, rev $181.9M vs P/E 39, rev $24.57B
Collegium Pharmaceutical Inc (COLL) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the COLL and DHR stock pages for the full models.
Not investment advice.